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Background Respiratory syncytial virus (RSV) is an important risk factor of asthma 
development and is responsible for severe respiratory tract infections. However, the 
influence of RSV infection on barrier function of bronchial epithelial cells in vitro and in vivo 
is still unclear.  
Objective The aim of this study was to analyze the role of RSV in tight junction (TJ) regulation 
and to compare epithelial integrity between asthmatic and healthy individuals upon RSV 
infection. 
Methods Healthy and asthmatic human bronchial epithelial cells (HBECs) were differentiated 
at air-liquid interface (ALI) and infected with RSV and UV-irradiated RSV. TJ expression and 
their integrity were analysed by qPCR, transepithelial resistance (TER) and paracellular flux. 
To determine the effect in vivo, Balb/c mice were intranasally infected with RSV or UV-
irradiated RSV A2. Bronchoalveolar lavage and TJ integrity were analysed on days 1, 2, 4 and 
6 post infection by qPCR, bioplex and confocal microscopy.  
Results RSV increased barrier integrity in ALI cultures of HBEC from healthy subjects, but no 
effect was found in HBECs from asthmatics. This was not associated with an increase in TJ 
mRNA expression. In vivo, RSV induced lung inflammation in mice and downregulated 
claudin-1 and occludin mRNA expression in the whole lungs. Surprisingly, RSV infection was 
not observed in bronchial epithelial cells, but was found in the lung parenchyma. Decreased 
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expression of occludin upon RSV infection was visible in mouse bronchial epithelial cells in 
confocal microscopy. However, there was no regulation of claudin-1 and claudin-7 at protein 
level. 
 
Keywords tight junctions, respiratory syncytial virus, asthma, airway epithelial cells 
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Introduction 
Human respiratory syncytial virus (RSV) is a negative-sense, single-stranded virus, which 
belongs to the Paramyxoviridae family. RSV is not only infecting epithelial cells in the upper 
airways of adults, but is also the leading cause of lower respiratory tract infections in infants 
under the age of 2 years.(1) Infections in children result in more severe, lower respiratory 
tract inflammation, leading in some cases to severe bronchiolitis, pneumonia and resulting in 
hospitalization.(2-4) In addition, RSV infection in childhood has been linked to recurrent 
wheeze, induction of childhood asthma and sensitization to allergens.(5-9) However, it is 
unclear how RSV and other respiratory viruses are propagating in vivo and how RSV is linked 
to the development of asthma and allergies. In case of rhinovirus infection, asthmatics 
display impaired interferon (IFN) production in response to infection (10, 11), but on the 
other hand no IFN deficiency was observed in well-controlled asthma.(12) In addition, 
a recent study suggested that there is no difference in IFN response to RSV between 
asthmatic and non-asthmatic individuals.(13) However, a study on hospitalized infants 
infected with RSV demonstrated diminished IFN-γ production at the time of bronchiolitis. 
Reduced IFN-γ production was related to development of asthma after bronchiolitis 
in infants.(14)  
Infection with RSV induces secretion of cytokines and chemokines from epithelial cells 
and resident leukocytes, which in turn leads to recruitment of circulating leukocytes to the 
infected lungs. (15) It has been demonstrated that RSV stimulates release of chemokines 
i.e. RANTES (regulated upon activation, normal T-cell expressed and secreted), MIP-1α, 
MIP-1β (macrophage inflammatory protein 1), MCP-1 (monocyte chemoattractant protein-
1), KC (neutrophil chemoattractant), as well as cytokines, such as G-CSF (granulocyte-colony 
stimulating factor), IL-6 and IL-1β.(16-18) 
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Tight junctions (TJ) form an essential part of the barrier between the mucosa or skin 
and the environment by connecting adjacent epithelial cells. A continuous band of TJ 
surrounds every epithelial cell and builds the most apical, extracellular cell-cell adhesion 
complex. TJ consist of large, transmembrane protein complexes with members of the claudin 
family, the MAL and related proteins for vesicle trafficking and membrane link (MARVEL) 
family, and the junctional adhesion molecule (JAM) family, which connect adjacent cells.(19, 
20) Cell types from different human tissues express a unique pattern of TJ proteins according 
to their specialization.(21) TJ are important in barrier formation. They prevent particles and 
pathogens from penetrating the tissue, control extracellular fluid, paracellular flux of 
molecules, and provide the apico-basolateral axis of differentiation.(22) Epithelial barrier 
defects due to disruptions in TJ have been reported in several allergic 
and inflammatory diseases, such as atopic dermatitis, asthma, and chronic rhinosinusitis, and 
a role of TJ in smooth muscle cells in asthma has been described.(23-28) The connection 
between RSV infections, barrier function, and the impact of the virus on asthma 
development has not been thoroughly studied. So far, RSV-induced disruption of barrier 
function in a bronchial epithelial cell line and contradictory results of induction of TJ 
molecules in human nasal epithelial cells have been reported.(29, 30) Although there is some 
evidence of epithelial barrier dysfunction in asthma (31) (32), it is still not clear whether RSV 
infection may have an influence on TJ in asthma.  
Therefore, the aim of this study was to identify the role of RSV in TJ regulation and function 
of epithelial integrity in vitro in asthmatic and healthy bronchial epithelial cell cultures. We 
also sought to explore the course of RSV infection in vivo using mouse model to mimic the 
situation in which RSV infection precedes asthma development and analyze here the 
inflammatory response and the regulation of TJ. 
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Material and Methods 
RSV propagation 
5 x106/ml HEp2 cells were incubated overnight at 37°C, 5 % CO2 in complete DMEM/F12 
medium. After 24 hours, the cells were washed with serum free DMEM/F12 medium. The 
cultures were infected with human RSV (type A, strain A2 (ATCC, Middlesex UK)) at a virus 
concentration of 0.1 pfu/cell and cultured in serum free DMEM/F12 at 37°C, 5 % CO2 for 48 
hours. After this time, the cytopathic effect was assessed and the cells were harvested using 
a cell scraper. Cultures were centrifuged and the resultant supernatant was snap frozen as 
viral stock in liquid nitrogen. Viral stocks were kept at –80°C until use. Control flasks of 
uninfected HEp2 cells were treated in the same way as control supernatants. 
 
Isolation of primary bronchial epithelial cells and ALI cultures  
Primary human bronchial epithelial cells (HBECs) were obtained from asthmatic patients 
undergoing bronchoscopy and bronchial brushings after written informed consent by each 
patient. Healthy HBECs were bought from Lonza. Cells were removed from brushes, seeded 
into collagen and fibronectin coated 25 cm2 T flasks and cultured in basal epithelial growth 
medium (BEGM, Lonza) at 37°C, 5 % CO2. 1.5x10
5 cells of passage 3 or 4 were seeded into 
collagen-precoated (Sigma) 24-well, polyester, 6.5 mm transwell plates (Corning) with 0.4 
µm pore size in ALI medium (DMEM (Gibco) 1:1 mixed with BEGM without triiodthyronine 
and freshly substituted with transretinoic acid (Sigma)). Apical medium was removed after 4 
days. Since our previous experiments (33) have demonstrated lower transepithelial 
resistance (TER) values in HBECs from asthmatic donors compared to control subjects, cells 
were used for the experiment when ALI cultures from healthy donors reached at least 
330 Ω*cm2 and asthmatic HBECs at least 200 Ω*cm2 in TER measurement with electrodes 
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and a Millicell ERS Volt-Ohm Meter (Millipore). The 6 healthy and 6 asthmatic cultures were 
apically infected with RSV (MOI of 1.5 or 0.15) or UV-irradiated RSV (UV-RSV) (MOI of 1.5) 
or incubated with control medium (u.s.). After 2h the cultures were washed 3 times 
and continued to be cultured at ALI.  
 
RSV mouse model 
Wild-type Balb/c mice, 8-12 weeks old, were maintained under specific pathogen-free 
conditions. Mice were housed at the Medical Research Council Centre for Inflammation 
Research, University of Edinburgh, United Kingdom, in individually ventilated cages for the 
duration of the study, and all experimental procedures were carried out in accordance with 
Home Office regulations. Mice were infected intranasally with 7.4 x 105 PFU RSV A2 or UV-
irradiated RSV, or left naïve. Mice were sacrificed at day 1, 2, 4 and 6 after infection (Figure 
S1A). Group size was n=8 and the experiment was repeated 3 times. 
 
BAL protein concentration and bioplex analysis 
Bronchoalveolar lavage (BAL) was obtained by injecting 1 ml of PBS containing protease 
inhibitor (Roche) into the mouse lung and retrieving usually 650-900 µl of injected fluid. The 
BAL supernatant was collected and total protein concentration was measured by a standard 
Bradford assay (BioRad). Bioplex analysis of the BAL has been done with Bio-Plex Pro™ 
Mouse Cytokine 23-plex Assay with the Bio-Plex 200 System (Bio Rad). 
 
mRNA isolation and quantitative RT-PCR 
Lung samples were directly stored in RNAlater (Qiagen) and frozen for later analyses. 
Lungs were then shredded with ceramic beads in RLT buffer (Precellys®24 tissue 
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homogenizer, Bertin technologies). Cells from ALI cultures at day 6 after infection were 
directly lysed in RLT buffer, and RNA was subsequently isolated with the RNeasy Mini Kit 
(Qiagen) according to the manufacturer’s protocol. cDNA was prepared with reverse 
transcription reagents containing random hexamer primers (Fermentas). For relative 
quantification, cDNA was amplified in the presence of SYBR Green and detected by an ABI 
PRISM 7000 Sequence Detection System (Applied Biosystems). Primer sequences for human 
and mouse primers can be found in supplementary Table 1. For human samples elongation 
factor 1α (EF1α) and for mouse samples glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) or EF1α were used as internal control. Relative expression of mRNA was calculated 
using the comparative ΔΔCT-method.(34) 
 
Lung histology and immunofluorescence staining of ALI and lung sections 
For confocal microscopy, lung samples were frozen in Tissue Tek (Sakura, Finetek) and cut 
into 30 µm thick sections with a cryomicrotome (Microm; Carl Zeiss). Lung sections were 
fixed with 4 % paraformaldehyde, blocked and permeabilized with PBS containing 10 % 
donkey serum (Sigma-Aldrich), 1 % BSA (Sigma-Aldrich), 0.1 % Triton-X 100 (Acros Organics), 
and 0.02% SDS (Sigma-Aldrich). Samples were stained with Alexa488-labelled mouse anti-
occludin, polyclonal rabbit anti-claudin-1, polyclonal rabbit anti-claudin-7 and polyclonal 
goat anti-RSV (AbD serotec) antibodies and detected with secondary antibodies labelled with 
Alexa-488, 546, or 633 (Invitrogen). Stainings were mounted in ProLong-Gold with DAPI 
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Statistical analysis 
Non-parametric data were analyzed using the Mann Whitney U test, while paired data 
sets were analyzed using the Wilcoxon matched pair test. Spearman’s correlation test was 
used between RSV load and chemokines, cytokines and TJ. All statistical analysis was 
conducted using the GraphPad Prism 5c software. A p-value <0.05 was considered 
statistically significant. 
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Results 
RSV increased barrier integrity in healthy, but not in asthmatic bronchial epithelial cells   
To determine the direct role of RSV on TJ of healthy and asthmatic HBECs, cells were 
cultured under ALI conditions and infected with RSV MOI of 0.15 or 1.5. Controls were 
treated either with medium or UV-RSV. As reported previously, we also noted that the 
baseline epithelial integrity is compromised in asthmatics compared to controls. (33) We 
demonstrated here that RSV increased transepithelial resistance (TER) and decreased 
paracellular flux in healthy, but not in asthmatic subjects (Figure 1A). As a control, we 
confirmed RSV infection of healthy and asthmatic HBECs (Figure 1B). On day 6 post infection, 
HBEC culture were harvested and analysed. Interestingly, virus load in asthmatic HBECs 
seemed to be lower than that observed in healthy individuals, yet this difference was not 
statistically significant. The expression of the TJ genes – occludin, claudin-1 and claudin-7 –  
were not significantly regulated on mRNA level in both groups (Figure 1C). Thus, our findings 
suggest that healthy HBECs’ response to RSV leads to an increase in epithelial barrier 
integrity reflected by decreased paracellular flux and enhanced transepithelial resistance, 
which does not occur in asthmatic patients. However, this effect was not due to a change in 
the expression of TJ molecules mRNA in HBECs.  
 
RSV infected mouse lungs and induced inflammation  
Since in the clinic, RSV infections in infants usually precede asthma development, 
we aimed to investigate the effect on lung epithelial barrier function in vivo. For this reason, 
mice were inoculated intranasally with RSV or UV-RSV. Mouse lungs and BAL were harvested 
on days 1, 2, 4 and 6 post infection (Figure S1A). Confirming the RSV infection in the lungs, 
we found high viral gene expression in RSV-infected mice, whereas there was no infection in 
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control naïve mice or in the UV-RSV-receiving control group already at day 1 after infection, 
persisting up to day 4 (Figure 2A). To investigate the influence of viral infection on barrier 
integrity and to get an insight into the inflammatory process in the lung, we performed a 
standard in vivo bronchoalveolar lavage (BAL) procedure and analysis. An increased protein 
influx from the lung parenchyma to the BAL on days 2, 4 and 6 indicated a reduction of the 
epithelial barrier integrity (Figure 2B). Furthermore, we found an increased expression of 
MUC5AC mRNA on days 1, 4 and 6 upon RSV infection, which suggested an induction of 
innate immune response in the epithelium (Figure 2C). In parallel, MUC5AC mRNA 
expression and overall increase in BAL protein content correlated with the viral load (Figure 
S1B). Among the BAL proteins there were proinflammatory cytokines and chemokines, such 
as IL-1β, IL-6, IL-12 p40, MCP-1, MIP-1α and MIP-1β, G-CSF, KC (neutrophil chemoattractant) 
and RANTES, of which most increased significantly upon RSV infection at day 1, 2, 4 and 6 
(Figure 2D). Released chemokines and cytokines positively correlated with RSV load in the 
lung (Figure S1C). In conclusion, RSV infection in vivo induced active lung inflammation and 
reduced airway epithelial barrier function.  
 
RSV infection downregulated TJ in mouse lungs  
To further characterize the mechanisms of barrier dysfunction upon RSV infection 
in vivo, detailed qPCR analysis of TJ in RSV and UV-RSV-infected mice was performed. 
In mouse lungs, a distinct set of TJ was found. All claudin family members, except claudin-2 
and claudin-6, the MARVEL family members – occludin, tricellulin and marvelD3 splice 
variant 2 (MarvelD3.2), as well as the junctional adhesion molecules – JAM-A, -B and –C 
and plaque protein zonula occludens (ZO) 1 genes were expressed (Figure S2A). Claudin-1 
was significantly downregulated on days 1 and 6 post infection and there was a trend 
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towards the decrease on days 2 and 4. Occludin was significantly downregulated only on day 
1 and showed a tendency to be downregulated on days 4 and 6 (Figure 3A). In addition, 
claudin-1 and occludin negatively correlated with RSV load in the lungs of infected mice 
(Figure 3B). In contrast, claudin-7 was upregulated in RSV-infected compared to naïve mice 
on day 1, but did not correlate with the RSV load (Figure S2B). Other TJ, such as claudin-10b 
and tricellulin were significantly downregulated compared to naïve at day 1 after infection. 
(Figure S2C). In conclusion, RSV infection led to the downregulation of claudin-1 
and occludin mRNA in mouse lungs, which correlated with barrier dysfunction and viral load. 
 
RSV was only found in the lung parenchyma and did not directly regulate TJ in mouse 
bronchial epithelial cells 
To determine the regulation of TJ and location of RSV infection in mouse lungs, 
immunofluorescence staining of TJ and RSV envelope proteins was performed. Interestingly, 
we demonstrated that already at day 1 post infection, RSV was located in the lung 
parenchyma, but was not found in the bronchial epithelial cells (Figure 4, Figure S3). 
Moreover, we found that occludin expression in the bronchial epithelium was lower in the 
RSV-infected mouse as compared to UV-RSV at day 2 and day 4  (Figure 4) and corresponded 
to  occludin mRNA expression level, correlation with viral load and increased protein leak to 
the BAL at day 2. However, there was no visible regulation of the protein expression of 
claudin-1 (Figure S3A) or claudin-7 (Figure S3B), suggesting that the stability of these 
proteins might be greater than occludin and that they are additionally highly regulated at the 
post-transcriptional level. To conclude, RSV infection correlated with the decreased occludin 
expression in the bronchial epithelium, while the expression of other TJ proteins was 
influenced at the transcriptional level in the whole lungs. 
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Discussion 
The aim of this study was to investigate the role of RSV infection in TJ regulation. We first 
sought to investigate the effect of RSV on TJ in asthmatic HBECs and healthy controls, 
and secondly, to study RSV effects on TJ integrity in mouse model of infection, which usually 
precedes asthma development.  
We found that RSV infection of primary HBECs led to an increase in barrier function 
in healthy, but not in asthmatic subjects. This was reflected by the change in barrier function 
parameters (TER, flux), but not by TJ gene expression level, suggesting very early innate 
response to RSV infection only in healthy epithelium. It is possible that Th2-type 
inflammation ongoing in allergic asthmatic patients alters epithelial cell function and 
precludes barrier tightening in response to RSV. This hypothesis is supported by the fact that 
normal bronchial epithelial cells stimulated with IL-4 and IL-13 demonstrate significant 
decrease in barrier integrity similar to that observed in HBECs from asthmatic patients. (33) 
Additionally, Th2 environment may interfere with the viral replication. Virus load at day 6 
post infection in asthmatic HBECs was lower compared to healthy individuals HBECs. 
Similarly, significantly diminished proliferation of parainfluenza virus (another 
Paramyxoviridae family member) has been demonstrated in nasal epithelial cells from 
allergic individuals. (35) These results suggest that already compromised barrier function in 
asthmatic is unable to react efficiently to RSV infection and provide natural defence 
mechanisms, however decrease in barrier function do not result in the increase of virus load 
in asthmatic HBECs. 
Thus, we observed here an additional dysfunction of asthmatic epithelium, which extends 
other observation of impaired innate mechanisms in response to viral infections (36, 37). 
These data are in line with previous observations that RSV infection of human nasal 
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epithelial cells results in enhanced expression of claudin-4 and occludin, inducing cell 
polarity, which may facilitate virus budding. (30) (38)  
The next aim of our study was to examine the influence of RSV on barrier function in vivo in 
a mouse model of RSV infection. We found that RSV was present only in the lung 
parenchyma, whereas the murine bronchial epithelial cells did not appear to be infected. 
We hypothesise that RSV might influence TJ expression in lung parenchyma cells either 
directly upon replication or indirectly via activation of inflammatory mediators. Similar RSV 
infection pattern has been found in children with severe RSV infection.(2, 39) This effect may 
be associated with the immature immune response and smaller physical dimensions of 
child’s airways, which may be a potential explanation of the viral location in the infant’s 
lungs.(40) Therefore, our results suggest that mouse model of RSV infection may mimic the 
course of infection in infants, which is related to disruption of the distal airway epithelium.  
On the other hand, RSV-induced barrier response in primary bronchial epithelial cells from 
adults might not be fully reflected in mouse model of infection. It has been demonstrated 
that BALB/c mice used in our study are semi-permissive to RSV infection and develop only 
limited inflammation. (41) In view of differences in the immune response and physical 
differences of lung structure between adults and infants, localization of the infection in 
adults is not limited to the lung parenchyma, but rather located in the upper airway 
epithelium. Therefore, being aware of the fact that mouse model of RSV infection may not 
reflect the range of pathologies observed in humans, we do not compare directly the results 
obtained in vitro with in vivo mouse model. It is possible that using another rodent model of 
RSV infection, i.e. cotton rats, we would be able to detect virus in epithelial cells of the lungs. 
(42) (43). On the reverse note, in vitro experiments with one type of cells might reflect only 
the early response of epithelium to the replication of virus and probably do not fully reflect 
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other events during on-going RSV-induced inflammation. Thus, we believe the results 
obtained from both experimental models complement each other and give different 
information: (i) in contrast to healthy controls, adult asthmatic epithelium is not able to 
provide resistance to RSV infection by tightening already compromised TJs barrier; and (ii) in 
vivo RSV-infection and following RSV-induced inflammation decrease whole lung barrier 
function, which possibly might contribute to further development of asthma. 
In summary, our data demonstrated that RSV infection increased barrier integrity in 
healthy, which mechanism was impaired in asthmatic bronchial epithelial cells. We also 
demonstrated that in in vivo mouse model RSV is located in lung parenchyma and RSV 
infection dysregulated TJ expression and function in the whole lung. However, further 
studies are needed to elucidate the link between RSV infection and barrier function. 
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Figure legend 
 
Figure 1. Infection of human healthy and asthmatic NHBE with RSV and its effect on TJ.  
(A) TER analysis and paracellular flux analysis of healthy (n=6) and asthmatic (n=6) bronchial 
epithelial cell cultures infected with UV-RSV, RSV MOI 0.15, RSV MOI 1.5 and medium 
control (u.s.). (B) qPCR analysis of RSV N gene to determine the viral load of these cultures at 
day 6 after infection. (C) qPCR analysis of occludin, claudin-1 and claudin-7 of these cultures 
at day 6 after infection.  
 
Figure 2. RSV infection leads to inflammation in the lungs.  
(A) qPCR analysis of RSV N gene in the mouse lungs after the infection with RSV to determine 
the viral load. (B) Bradford assay of BAL to show protein influx into the lung lumen and (C) 
MUC5AC mRNA expression in the lung in naïve and post infection with RSV. (D) Level of IL-
1β, IL-6, IL-12 p40, MCP-1, MIP-1α, MIP-1β, G-CSF, KC and RANTES in BAL. n=8, experiments 
were repeated 3 times.  
 
Figure 3. TJ gene expression is regulated by RSV in mouse lungs.   
(A) qPCR analysis of claudin-1 and occludin in the lung post infection with RSV compared to 
naïve and (B) their correlation with the RSV load. n=8, experiments were repeated 3 times. 
 
Figure 4. RSV is located in the mouse lung parenchyma.  
Representative confocal staining of occludin (green) and RSV (red) post infection with RSV 
and naïve control mouse lung. DAPI is stained in blue. Experiments were repeated 3 times. 
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Figure S1: (A) Experimental protocol. Balb/c mice were infected intranasally with 7.4 x 105 
PFU RSV A2 or UV-irradiated RSV, or left naïve, and lung tissue was analysed at 1, 2, 4, 6 days 
post infection with RSV A2, n=8. Experiments were repeated 3 times. (B) Correlations of 
protein influx and MUC5AC mRNA with the RSV load. (C) Correlation of IL-1β, IL-6, IL-12p40, 
MCP-1, MIP-1α, MIP-1β, G-CSF, KC, RANTES with the viral load. All detectable values of the 
each experiment are included in the graphs. 
 
Figure S2: (A) qPCR analysis of the mRNA expression of the claudin, Marvel, JAM and ZO 
families in naïve mouse lungs. (B) Claudin-7 gene expression and its correlation with the viral 
load. (C) Claudin-4, claudin-10b and tricellulin gene expression. 
 
Figure S3: Confocal microscopy of (A) claudin-1 (green) and (B) claudin-7 (green) and RSV 
(red) in naïve, UV-RSV and RSV-inoculated mice. 
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Claudin-1 GCC TTG GCT GTA CCT TAC CAT CT CTT ATC CCC CTT TGA GTG TGA TT 
Claudin-2 GCA AAC AGG CTC CGA AGA TAC T GAG ATG ATG CCC AAG TAC AGA G 
Claudin-3 CCT GTG GAT GAA CTG CGT G GTA GTC CTT GCG GTC GTA G 
Claudin-5 TGT GTC TGG TAG GAT GGG TG AGT TCT TCT TGT CGT AAT CGC C 
Claudin-6 CGG CAA CAG CAT CGT CGT G TCT TGG TGG GAT ATT CGG AGG 
Claudin-7 AGC ATG TTC CTG GAT TGG TC CTC CCC AGC TCA CAC GTA TT 
Claudin-8 GCA ACC TAC GCT CTT CAA ATG G TGG TGC GAT GGG ATG GTA C 
Claudin-9 TTC CAC CTG CGG CTT CAT TCG CAG GCG CAT GGA T 
Claudin-11 GGT GGT GAC CTG CAG CTA CA GCC CTT GGA GCC CAG TTC 
Claudin-12 
TGC ATC TGA GTT CAC TAA GCT GAC 
T 
CCT GTC TGC GCC TCT GAT C 
Claudin-15 TGC AGG GAC CCT CCA CAT ACG GCG TAC CAC GAG ATA GC 
Claudin-16 CTC CTC ACC TGC TGT TTG TAC CT AGG GCT TCC TCA TGG CAT AA 
Claudin-17 CGA GAA CTT GGA GGA GCA CTC T GCC CGC CTC CAA TGA AG 
Claudin-10a TTC GTG GAA GTT TTG TCC AG CCA CAC ACC AGA GCT GAG AT 
Claudin-10b AGG AGT TCC CCT CCA TGC T ACC GCA GCG ATC ATT AGT C 
Claudin-13 ATG GTC GTC AGC AAA CAA GAG G TCA AAC ATC TAA GGT ATC GTT G 
Claudin-14 AAA GGC ACA CCC GCC AAG ACC A 
CCC GAT GAG AGA CAG GGA TGA 
GGA 
Claudin-18 ACC GCC GTG TTC CAG TAT GAA G TGA TTG CAC AGA TGC CGG AGA 
Claudin-19 CGG TCA TAT CCA GTC AGC ACG A 
AGA CCT GCC AAG AGG AAG AGA 
GCA 
Claudin-20 CAG CTC CTT GCT TTC ATC CTG CAG ACT CCT CCA GCA AAG GAA 
Claudin-22 
GCT CCT GCA GCC TCG AGT CAC TAT 
G 
TGG ATT GGC TTG CTT CAG CTC CA 
Claudin-23 ACA GGG ACA CCA GCA AGC TCA A 
AGG TCA GAG TCA CAG GGC AAC 
GAA 
GAPDH TGC ACC ACC AAC TGC TTA G GGA TGC AGG GAT GAT GTT C 
EF1A CGGCAGTCGCCTTGGACGTT CGGTGGTTTTCACAACACCTGCGT 
Jam-A GGC TTC TCC TCT CCC CGA GTG G CG GTC CGC ATA GGG AGC TGT 
Jam-B CCA ACA GGC TCT CCA AGG TGA CTT TCG GAG CGC TGA CTT CAC AGC 
Jam-C TGT GCA AGT GAA GCC AGT GAC CC AGC CCT CGC TCT CTT GGC ACT 
MarvelD3.1 GGG CTT CGG AAA GAT ACG TG CAC CGT CAA AGC CAC TAT AAG 
MarvelD3.2 CTC CTG GAT TGC CAC AAA TG GTG CCC TCA AAA GGT GAG TA 
Tricellulin CTC GGA GAC ATC GGG AGT TC CTC GGA GAC ATC GGG AGT TC 




Claudin-1 CAGTCAATGCCAGGTACGAATTT AAGTAGGGCACCTCCCAGAAG 
Claudin-7 GGGCATGAAGTGCACGCGCT CGGCAAGACCTGCCACGATG 
GAPDH ACC CAC TCC ACC TTT GA TGA CAA AGT GGT CGT TGA GGG 
EF1A CTG AAC CAT CCA GGC CAA AT GCC GTG TGG CAA TCC AAT 
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Occludin GATGAGCAGCCCCCCAAT GGTGAAGGCACGTCCTGTGT 
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